Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMVIA: imatinib plus surgery versus imatinib alone for recurrent or metastatic c-kit positive gastrointestinal stromal tumor
ChiCTR-PRC-08000244Phase 4Completed
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of imatinib in gastrointestinal stromal tumor (GIST) (2 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoint: 2-year progression-free survival. Started Jun 2008; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR-PRC-08000244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-08000244.